Australia, Feb. 21 -- Prothena Biosciences Ltd., owns the trademark (2480053) for 'BIRCLERZI' till July 12, 2034.
Status: protected:
Registered/protected
Classes: 5 [Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.], 42 [Research and development in the pharmaceutical and biotechnology fields.] and 45 [Licensing of intellectual property in the field of biotechnology.]
Type of Mark: Word
Date of Acceptance: Sept. 6, 2024
Registration Advertised: Feb. 20
For further details contact Tomkins & Co. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2480053.
Disclaimer: Curated by HT Syndication.
